Nebula Research & Development LLC Adaptive Biotechnologies Corp Transaction History

Nebula Research & Development LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$2.34 - $3.96 $21,853 - $36,982	-9,339 Reduced 38.35%	15,011 $54.3 Million
Q1 2024 May 15, 2024	SELL	$2.88 - $4.8 $115,640 - $192,734	-40,153 Reduced 62.25%	24,350 $78.2 Million
Q4 2023 Feb 14, 2024	BUY	$3.46 - $5.33 $81,067 - $124,881	23,430 Added 57.04%	64,503 $316 Million
Q3 2023 Nov 14, 2023	BUY	$5.07 - $8.44 $208,240 - $346,656	41,073 New	41,073 $224 Million

202

146M

68.8K

42.5K

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $849M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

Get notified when there are updates to the investment portfolio of Nebula Research & Development LLC, based on Form 13F filings with the SEC.

Stay updated on Nebula Research & Development LLC with notifications on news.